PRFX

distress 1/10 · well-funded / low risk

$1.18-2%today-90% from 52w high

painreform.com6 employeesFounded 2007Tel Aviv-Yafo, IsraelDrug Manufacturers - Specialty & Generic

Revenue

pre-revenue

Liquidity

$11M

Runway

2.7 yrs

Shares 1y

Price & events

-74.6% over 6M

CatalystRating changeDilutionFinancingdashed = today

-2.1%

-0.4%

-19.0%

-51.2%

-70.0%

-84.2%

-90.8%

-99.9%

All

Overview

Market Cap: $975.97K
Volume: 17.75K
52 Week Range: $1.15 – $11.85
Total Shares: 830.61K
Float Shares: 844.37K
Short %: 4.20%
% Held by Insiders: 0.00%
% Held by Institutions: 0.52%
RVOL: 0.01x
Beta: 1.05

Pipeline · 0 trials · 0 upcoming

Readout	Phase	Drug	Indication	Enroll	Status
No pipeline trials tracked.

Catalyst news & presentations · 0

No catalyst news yet.

Approved drugs (0)

none — clinical-stage

Capital structure — dilution & financing

Shares out: 830,613 · 2 offerings/1y · 0 PIPEs

2026-06-29EFFECTshelf_effective
2026-06-29424B3offering
2026-06-22F-1shelf_registration
2026-05-19424B3offering
2026-05-19EFFECTshelf_effective
2026-05-13F-1shelf_registration
2025-05-09EFFECTshelf_effective

🔒 Positioning — Pro

Short interest / days-to-cover, insider buys & sells.

Upgrade to Pro

🔒 Top holders — Pro

Institutional ownership + quarter-over-quarter accumulation/trimming.

Upgrade to Pro

Wall St ratings

no consensus

2024-10-24Maxim GroupBuy → Hold

Competitors

none identified